Careram (iguratimod) / Fujifilm Holdings, R-Pharm, Eisai  >>  Phase 4
Welcome,         Profile    Billing    Logout  

3 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Careram (iguratimod) / Eisai, R-Pharm
NCT04928066: The Efficacy and Safety of Tofacitinib (TF) With Iguratimod (IGU) on RA

Completed
4
100
RoW
Iguratimod, IGU, T-614, Tofacitinib, TF, Pred, Prednisone
Qilu Hospital of Shandong University
Arthritis, Rheumatoid
06/23
07/23
NCT05626348: The Clinical Efficacy of Immunomodulators in RA Patients

Recruiting
4
400
RoW
Iguratimod, IGU, T-614, Methotrexate, MTX, Adalimumab Injection, adalimu, Leflunomide, LEF, Hydroxychloroquine, HCQ
Qilu Hospital of Shandong University
Arthritis, Rheumatoid
06/25
12/26
NCT03855007: The Clinical Efficacy and Safety of Iguratimod in RA and Early RA Patients for 6 Months Treatment

Completed
4
400
RoW
Iguratimod, T-614, MTX, methotrexate, HCQ, Hydroxychloroquine, Pred, Prednisone
Qilu Hospital of Shandong University
Arthritis, Rheumatoid
09/23
10/23

Download Options